Evidence for Right Ventricular Lipotoxicity in Heritable Pulmonary Arterial Hypertension
- 1 February 2014
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 189 (3) , 325-334
Abstract
Rationale: Shorter survival in heritable pulmonary arterial hypertension (HPAH), often due to BMPR2 mutation, has been described in association with impaired right ventricle (RV) compensation. HPAH animal models are insulin resistant, and cells with BMPR2 mutation have impaired fatty acid oxidation, but whether these findings affect the RV in HPAH is unknown. Objectives: To test the hypothesis that BMPR2 mutation impairs RV hypertrophic responses in association with lipid deposition. Methods: RV hypertrophy was assessed in two models of mutant Bmpr2 expression, smooth muscle–specific (Sm22R899X) and universal expression (Rosa26R899X). Littermate control mice underwent the same stress using pulmonary artery banding (Low-PAB). Lipid content was assessed in rodent and human HPAH RVs and in Rosa26R899X mice after metformin administration. RV microarrays were performed using human HPAH and control subjects. Results: RV/(left ventricle + septum) did not rise directly in proportion to RV systolic pressure in Rosa26R899X but did in Sm22R899X (P < 0.05). Rosa26R899X RVs demonstrated intracardiomyocyte triglyceride deposition not present in Low-PAB (P < 0.05). RV lipid deposition was identified in human HPAH RVs but not in controls. Microarray analysis demonstrated defects in fatty acid oxidation in human HPAH RVs. Metformin in Rosa26R899X mice resulted in reduced RV lipid deposition. Conclusions: These data demonstrate that Bmpr2 mutation affects RV stress responses in a transgenic rodent model. Impaired RV hypertrophy and triglyceride and ceramide deposition are present as a function of RV mutant Bmpr2 in mice; fatty acid oxidation impairment in human HPAH RVs may underlie this finding. Further study of how BMPR2 mediates RV lipotoxicity is warranted.Keywords
This publication has 34 references indexed in Scilit:
- Shorter Survival in Familial versus Idiopathic Pulmonary Arterial Hypertension is Associated with Hemodynamic Markers of Impaired Right Ventricular FunctionPulmonary Circulation, 2013
- Inhibition of Serine Palmitoyl Transferase I Reduces Cardiac Ceramide Levels and Increases Glycolysis Rates following Diet-Induced Insulin ResistancePLOS ONE, 2012
- Rho-kinase inhibition alleviates pulmonary hypertension in transgenic mice expressing a dominant-negative type II bone morphogenetic protein receptor geneAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- ACE2 Improves Right Ventricular Function in a Pressure Overload ModelPLOS ONE, 2011
- Heart Sphingolipids in Health and Disease2011
- Plasma Levels of High-Density Lipoprotein Cholesterol and Outcomes in Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Fatty Acid Oxidation and Malonyl-CoA Decarboxylase in the Vascular Remodeling of Pulmonary HypertensionScience Translational Medicine, 2010
- Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management EraCirculation, 2010
- Lipotoxicity in the heartBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Insulin resistance in pulmonary arterial hypertensionEuropean Respiratory Journal, 2008